We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA’s Generics Backlog Is Hurting Competition, Lawmaker Says
FDA’s Generics Backlog Is Hurting Competition, Lawmaker Says
Sen. David Vitter is asking the FDA to process its current backlog of more than 3,000 generic drug applications, especially in light of recent prescription drug price increases.